
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
[ Thu, Jun 09th 2022 ]: WOPRAI
Nick Giovacchini Maintained (CCRN) at Hold with Decreased Target to $26 on, Jun 9th, 2022


🞛 This publication is a summary or evaluation of another publication
Nick Giovacchini of Credit Suisse, Maintained "Cross Country Healthcare, Inc." (CCRN) at Hold with Decreased Target from $28 to $26 on, Jun 9th, 2022.
Nick has made no other calls on CCRN in the last 4 months.
There is 1 other peer that has a rating on CCRN. Out of the 1 peers that are also analyzing CCRN, 0 agree with Nick's Rating of Hold.
This is the rating of the analyst that currently disagrees with Nick
- Bill Sutherland of "Benchmark" Maintained at Strong Buy with Increased Target to $42 on, Thursday, February 24th, 2022